Skip to content

CDR

Giancamilli to step down as Katz CEO

Andy Giancamilli, who for the past eight years has kept Katz Group Canada Ltd. in the forefront of efforts to secure a bigger role in health care for community pharmacy, will retire as the company’s chief executive officer on February 2.

FTC will take close look at big PBM merger

The Federal Trade Commission’s request for more information on the planned merger of Express Scripts Inc. and Medco Health Solutions Inc. has opponents hoping the deal will be scuttled. Express Scripts says it expected the FTC’s request, and both companies have vowed to work with the agency.

‘Super committee’ gets overture from NACDS

Community pharmacy advocates say that the “super committee” on deficit reduction should collaborate with community pharmacy on reducing health care costs while maintaining patient access to prescription drugs and pharmacy services.

Drug chain same-store sales up, but consumers still wary

Drug chains posted strong results last month, although anemic sales in other retail channels suggest consumers remain reluctant to spend any more than necessary. Walgreen Co. recorded volume of $6.1 billion, up 7.8% over August 2010. Total front-end sales climbed 6.

Health reform act wins round in court

A federal appeals court here has dismissed two cases challenging the 2010 health care reform law, ruling the plaintiffs did not have grounds to sue. Two of the three judges on the panel said they would have upheld the law if they had been able to rule on the suits’ merits. Other

Cosby will bring change to CVS/pharmacy

or even distant — memory has a mass retailer tapped an outsider to head up its executive ranks. Yet that’s what is about to happen, on October 1, when Mark Cosby officially becomes president of the CVS/pharmacy unit of CVS Caremark. It is a daunting assignment. Depending on how one calculates

Giancamilli helps move community Rx ahead

When Andy Giancamilli steps down as chief executive officer of Katz Group Canada at the beginning of February, his move to an advisory role at the company will mark the end of a career in community pharmacy that exemplifies what the profession means for the people who practice it and the patients it

Dr. Reddy’s ships generic version of Exelon

Dr. Reddy’s Laboratories has launched rivastigmine tartrate capsules, a treatment for dementia caused by Alzheimer’s or Parkinson’s disease, in the U.S. market. The pharmaceutical company said Thursday that its rivastigmine tartrate capsules are available in strengths of 1.5 mg, 3 mg, 4.

Advil to air TV spots featuring Regis Philbin

Next month, Advil plans to launch a television advertisements featuring TV personality Regis Philbin and his wife Joy as part of the pain reliever’s "True Advil Stories" campaign. The Pfizer pain relief brand said Thursday that the TV commericals are available now on the TakeAdvil.

PhRMA names new board members

The Pharmaceutical Research and Manufacturers of America (PhRMA) has elected EMD Serono Inc. president James Hoyes and Ikaria Inc. chairman and chief executive officer Daniel Tassé to its board of directors. "We are pleased to welcome two outstanding industry leaders, Mr. Hoyes and Mr.

FDA urges Primatene Mist users to ready a replacement

The Food and Drug Administration is alerting users of over-the-counter asthma inhalers containing chlorofluorocarbons (CFCs) to get a prescription for a replacement medication since these products won’t be made or sold by the year’s end.